MYCELEX-G

Pre-LaunchSM

clotrimazole

NDAVAGINALTABLET
Lifecycle
Pre-Launch
Clinical Trials
6

Clinical Trials (5)

NCT03599323N/ACompleted

Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%)

Started Jul 2018
1,033 enrolled
Vaginal Candida
NCT02180828Phase 4Completed

Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis

Started Jul 2014
240 enrolled
Candidiasis, Vulvovaginal
NCT01993823Phase 3Completed

Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis

Started May 2013
NCT02184351Phase 3Completed

Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

Started May 2001
187 enrolled
Candidiasis, Oral
NCT00000676Phase 3Completed

Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)

500 enrolled
CandidiasisMycosesHIV Infections